TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22162258

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil capsules 500 mg twice/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (starch filled capsules)
Number of subjects: 40
Study: 21149761

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg/d)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 17605681

Group type: EXPERIMENTAL
Intervention: Transurethral radiofrequency collagen denaturation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 21
Study: 15657155

Group type: EXPERIMENTAL
Intervention: 6-sample at-home FOBT
Number of subjects: 3121

Group type: COMPARATOR
Intervention: Digital FOBT
Number of subjects: 3121
Study: 12127708

Group type: EXPERIMENTAL
Intervention: Cefaclor (40 mg/kg/day in two doses for 5 days)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Amoxycillin (40 mg/kg/day in three doses for 10 days)
Number of subjects: 384
Study: 10450594

Group type: EXPERIMENTAL
Intervention: External nasal dilator
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lateral position
Number of subjects: 18

Group type: COMPARATOR
Intervention: NREM sleep
Number of subjects: 18

Group type: COMPARATOR
Intervention: Stage 2 sleep
Number of subjects: 18
Study: 8539152

Group type: EXPERIMENTAL
Intervention: Fast chronotropic response (lower rate abruptly programmed to the expected value at 50% metabolic reserve)
Number of subjects: 10

Group type: COMPARATOR
Intervention: DDD (lower rate 60 beats/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Overpaced (lower rate at least 80% of the age predicted maximum)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fast chronotropic response
Number of subjects: 10
Study: 30817452

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 131
Study: 27626675

Group type: EXPERIMENTAL
Intervention: Stooped posture during negative mood induction
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Stooped posture
Number of subjects: 351

Group type: COMPARATOR
Intervention: Cognitive reappraisal instructions
Number of subjects: 351
Study: 25920384

Group type: EXPERIMENTAL
Intervention: Motivational interviewing, 6 weeks' worth of nicotine patches and gum, faxed referral to the state smokers' quitline, booster call, and brochure.
Number of subjects: 778

Group type: COMPARATOR
Intervention: Brochure providing quitline information.
Number of subjects: 778
Study: 23616495

Group type: EXPERIMENTAL
Intervention: Colistin plus rifampicin 600 mg every 12 hours intravenously
Number of subjects: 210

Group type: COMPARATOR
Intervention: Colistin alone, 2 MU every 8 hours intravenously
Number of subjects: 210
Study: 21863679

Group type: EXPERIMENTAL
Intervention: Effective-site target controlled infusion (TCI) of propofol with initial target concentration of 1.5 microg/ml.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manually controlled infusion (MCI) of propofol with initial bolus 0.5 mg/kg and initial infusion rate 1.5 mg/kg/hr.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Effective-site target controlled infusion (TCI) of propofol.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manually controlled infusion (MCI) of propofol.
Number of subjects: 60
Study: 18060280

Group type: EXPERIMENTAL
Intervention: Sodium picosulfate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mannitol
Number of subjects: 80
Study: 17564405

Group type: EXPERIMENTAL
Intervention: Mandibular advancement splint
Number of subjects: 73

Group type: COMPARATOR
Intervention: Inactive oral device
Number of subjects: 73
Study: 11827087

Group type: EXPERIMENTAL
Intervention: MP (modus ponens) premise forms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AC (affirming-the-consequent) premise forms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MP and AC arguments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AC inferences
Number of subjects: 0
Study: 10613279

Group type: EXPERIMENTAL
Intervention: Day-stay only
Number of subjects: 131

Group type: COMPARATOR
Intervention: Overnight-stay
Number of subjects: 131
Study: 7555937

Group type: EXPERIMENTAL
Intervention: Pull method with antibiotic prophylaxis (amoxycillin‐clavulanic acid 3 x 1.2 g i.v. over 24 hours); 37 patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pull method without antibiotic prophylaxis; 34 patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Push method without antibiotic prophylaxis; 29 patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pull method with antibiotic prophylaxis; 37 patients
Number of subjects: 100
Study: 1683094

Group type: EXPERIMENTAL
Intervention: Lithium carbonate added to neuroleptics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neuroleptics alone (control group)
Number of subjects: 0
Study: 6803871

Group type: EXPERIMENTAL
Intervention: Propranolol (480 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol (480 mg daily) during cold pressor test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg daily) during cold pressor test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol (480 mg daily) during mental arithmetic test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg daily) during mental arithmetic test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine and Propranolol together
Number of subjects: 0
Study: 30894063

Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both conditions (Rumination and Distraction)
Number of subjects: 0
Study: 30063804

Group type: EXPERIMENTAL
Intervention: Allogeneic adipose MSCs (ASCs) at 4 × 106 cells/kg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Allogeneic adipose MSCs (ASCs) at 1 × 106 cells/kg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Allogeneic adipose MSCs (ASCs) at 0.25 × 106 cells/kg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 27440681

Group type: COMPARATOR
Intervention: C80
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HF meals
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HF200
Number of subjects: 40

Group type: COMPARATOR
Intervention: C200 and C280
Number of subjects: 40
Study: 24535626

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50,000 IU every 4 weeks)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 203
Study: 22728943

Group type: EXPERIMENTAL
Intervention: Echinacea (ECH)
Number of subjects: 24
Study: 19143915

Group type: EXPERIMENTAL
Intervention: Flexible-dose sildenafil (50 or 100 mg)
Number of subjects: 209
Study: 17567823

Group type: EXPERIMENTAL
Intervention: ALERT Plus program (basic curriculum extended to ninth grade with five booster lessons)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control schools (basic ALERT curriculum covering seventh and eighth grades only)
Number of subjects: 0
Study: 16146457

Group type: EXPERIMENTAL
Intervention: CABG patients
Number of subjects: 393

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 393
Study: 12187064

Group type: EXPERIMENTAL
Intervention: Sequential methotrexate and 5-fluorouracil scheduling, epirubicin and cisplatin (MFAP regimen)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Bladder preservation
Number of subjects: 37

Group type: COMPARATOR
Intervention: Cystectomy group
Number of subjects: 37
Study: 10442596

Group type: EXPERIMENTAL
Intervention: Dietary caloric intake (88.1 ± 5.0 kcal/kg/d; range, 60 to 113 kcal/kg/d)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dietary caloric intake
Number of subjects: 12
Study: 8702200

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Thoracotomy (T-group)
Number of subjects: 24
Study: 2327561

Group type: EXPERIMENTAL
Intervention: Hyposensitization with extract from the house dust mite Dermatophagoides pteronyssinus (Dp) for 2 years
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Hyposensitization with extract from the house dust mite Dermatophagoides pteronyssinus (Dp)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (15 comparable patients)
Number of subjects: 31
Study: 343250

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride (up to 10 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study: 30830540

Group type: EXPERIMENTAL
Intervention: Adjuvant dendritic cell therapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Local treatment with curative intent
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Systemic treatment
Number of subjects: 120
Study: 29793126

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Proprioceptive Neuromuscular Facilitation (PNF)
Number of subjects: 42
Study: 27399503

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS) with Apollo device
Number of subjects: 222

Group type: COMPARATOR
Intervention: Best medical management (MM)
Number of subjects: 222
Study: 24670148

Group type: EXPERIMENTAL
Intervention: Paromomycin-miltefosine combination therapy
Number of subjects: 0
Study: 22987089

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (2 g/d)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study: 18755818

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 18001445

Group type: EXPERIMENTAL
Intervention: Oxytocin discontinued at the beginning of the active phase of labor
Number of subjects: 342

Group type: COMPARATOR
Intervention: Oxytocin continued until delivery
Number of subjects: 342
Study: 15958169

Group type: EXPERIMENTAL
Intervention: Total plaque volume measurement in subjects with diabetes/impaired glucose tolerance
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intima-media thickness measurement in subjects with diabetes/impaired glucose tolerance
Number of subjects: 98

Group type: COMPARATOR
Intervention: Total plaque volume measurement in normoglycemic controls
Number of subjects: 98

Group type: COMPARATOR
Intervention: Intima-media thickness measurement in normoglycemic controls
Number of subjects: 98
Study: 12131259

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation (20 g.d‐1 Cr + 180 g.d‐1 dextrose)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (200 g.d‐1 dextrose)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation
Number of subjects: 32
Study: 10765887

Group type: EXPERIMENTAL
Intervention: Subjects with 25 or more teeth (dentate)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Edentulous subjects
Number of subjects: 225
Study: 7588171

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 100-300 mg (mean daily dose 204 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clomipramine 50-150 mg (mean daily dose 106 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 40
Study: 2254102

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy (IHF) - 23 Gy in 4 fractions over 17 days
Number of subjects: 230

Group type: COMPARATOR
Intervention: Classical radiation therapy (IC) - 45 Gy in 25 fractions over 33 days
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy (IHF)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Classical radiation therapy (IC)
Number of subjects: 230
Study: 6782869

Group type: EXPERIMENTAL
Intervention: Travasol 8.5%
Number of subjects: 36

Group type: COMPARATOR
Intervention: FreAmine II 8.5%
Number of subjects: 36
Study: 29630433

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy with concurrent systemic therapy
Number of subjects: 20
Study: 27215779

Group type: EXPERIMENTAL
Intervention: Paracetamol (20 mg/kg loading dose within 24 hours of birth, followed by 7.5 mg/kg every 6 hours for 4 days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (0.45% NaCl)
Number of subjects: 48
Study: 24534379

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 612
Study: 22574568

Group type: EXPERIMENTAL
Intervention: Reinforcing manipulation of acupuncture
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reducing manipulation of acupuncture
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Needle-retaining group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Model group
Number of subjects: 60
Study: 20697273

Group type: EXPERIMENTAL
Intervention: Therapeutic ocular surface medium (TOSM)
Number of subjects: 46
Study: 18424191

Group type: EXPERIMENTAL
Intervention: Venlafaxine (75 mg once daily for 2 weeks, 150 mg once daily for 4 weeks, and 75 mg once daily for 2 weeks)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 15860246

Group type: EXPERIMENTAL
Intervention: 2.5 mg/day glipizide GITS
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 12933400

Group type: EXPERIMENTAL
Intervention: Hemisync sounds
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (blank cassette tape)
Number of subjects: 60
Study: 11732515

Group type: EXPERIMENTAL
Intervention: Ketoprofen 25 mg rectally with i.v. placebo
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Ketoprofen 25 mg i.v. with rectal placebo
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo both i.v. and rectally
Number of subjects: 123
Study: 8868334

Group type: EXPERIMENTAL
Intervention: Right-hemispheric P50m response (141.5 +/- 16.3 fT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Right-hemispheric P50m response (135.1 +/- 11.0 fT)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Right-hemispheric N100m response (484.4 +/- 28.4 fT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Right-hemispheric N100m response (405.8 +/- 27.9 fT)
Number of subjects: 37
Study: 1320919

Group type: EXPERIMENTAL
Intervention: Intravenous granisetron 40 micrograms/kg
Number of subjects: 996

Group type: COMPARATOR
Intervention: Intravenous granisetron 10 micrograms/kg
Number of subjects: 996

Group type: COMPARATOR
Intervention: Intravenous granisetron 2 micrograms/kg
Number of subjects: 996

Group type: EXPERIMENTAL
Intervention: Intravenous granisetron 3 mg single-dose regimen (equivalent to 40 micrograms/kg in a 75 kg person)
Number of subjects: 996
Study: 6468816

Group type: EXPERIMENTAL
Intervention: Propafenon (900 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Mexiletine (600 mg/day)
Number of subjects: 12
Study: 30895903

Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Vaginal pessary
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone 200 mg nocte
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 30352748

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU/day)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 30191830

Group type: EXPERIMENTAL
Intervention: Integrated intervention (systems navigation, psychosocial counselling, ART at any CD4 count)
Number of subjects: 1308

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 1308
Study: 27130691

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg every 2 weeks
Number of subjects: 769

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 769

Group type: EXPERIMENTAL
Intervention: Dupilumab (both doses)
Number of subjects: 769

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 769
Study: 25042759

Group type: EXPERIMENTAL
Intervention: Women's Recovery Group (WRG), n=52
Number of subjects: 158

Group type: COMPARATOR
Intervention: Group Drug Counseling (GDC), n=48
Number of subjects: 158
Study: 22713087

Group type: EXPERIMENTAL
Intervention: Sodium phosphate (NaP) tablets
Number of subjects: 92

Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG) solution
Number of subjects: 92
Study: 21162959

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (HES 130/0.4)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 4% succinylated gelatine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (H and G)
Number of subjects: 80
Study: 17670801

Group type: EXPERIMENTAL
Intervention: Red wine (150 ml, 15 g alcohol) daily for 3 weeks
Number of subjects: 87
Study: 15572657

Group type: EXPERIMENTAL
Intervention: CAA supplements (15 g of essential amino acids and 30 g of carbohydrate)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: CAA ingestion
Number of subjects: 13

Group type: COMPARATOR
Intervention: Liquid mixed meal (CON)
Number of subjects: 13
Study: 11874393

Group type: COMPARATOR
Intervention: (+)-chlorpheniramine 2 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: (+)-chlorpheniramine 6 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg
Number of subjects: 12
Study: 9664997

Group type: EXPERIMENTAL
Intervention: Neoral
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sandimmune
Number of subjects: 30
Study: 7540512

Group type: EXPERIMENTAL
Intervention: Haemodilution (haematocrit = 28%-32%)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Nonhaemodiluted group
Number of subjects: 32
Study: 2142968

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate and ethinylestradiol (2 mg cyproterone acetate + 0.035 mg ethinyl‐estradiol days 1‐21, +10 mg cyproterone acetate days 1‐15) (n = 15)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Dexamethasone (0.25‐0.5 mg daily at 10 pm) (n = 13)
Number of subjects: 28
Study: 769201

Group type: EXPERIMENTAL
Intervention: Sengstaken‐Blakemore tube
Number of subjects: 28

Group type: COMPARATOR
Intervention: Linton‐Nachlas tube
Number of subjects: 28
Study: 31222832

Group type: COMPARATOR
Intervention: Standard Monitoring (SM)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Capnography (CA)
Number of subjects: 150
Study: 30676139

Group type: EXPERIMENTAL
Intervention: HYPER (FiO2: 0.36)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: NORM‐DEC (FiO2: 0.36)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: NORM‐INFORM (FiO2: 0.21)
Number of subjects: 15

Group type: COMPARATOR
Intervention: NORM (FiO2: 0.21)
Number of subjects: 15
Study: 29216945

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass (CPB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (off‐pump ligation of ductus arteriosus)
Number of subjects: 40
Study: 25609246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Ganitumab 12 mg/kg
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Ganitumab 20 mg/kg
Number of subjects: 800
Study: 23710586

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation (CRT) with cisplatin 40 mg/m² weekly × 5
Number of subjects: 305

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 305
Study: 16818817

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: ICD therapy in NYHA class II
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: ICD therapy in NYHA class III
Number of subjects: 1000
Study: 10760105

Group type: EXPERIMENTAL
Intervention: Nutritional parameters (dietary protein intake, energy intake, serum albumin, transferrin, percentage body fat, skinfold thickness, urine creatinine excretion)
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Protein and energy intakes
Number of subjects: 1785

Group type: EXPERIMENTAL
Intervention: Anthropometric and biochemical nutritional parameters
Number of subjects: 1785
Study: 8614710

Group type: EXPERIMENTAL
Intervention: Single lumen catheters
Number of subjects: 188

Group type: COMPARATOR
Intervention: Double lumen catheters
Number of subjects: 188
Study: 1569387

Group type: EXPERIMENTAL
Intervention: Linoleate-diet (12.0% energy from linoleic acid)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Stearate-diet (11.8% energy from stearic acid)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Trans-diet (7.7% energy from trans fatty acids)
Number of subjects: 56
Study: 3912623

Group type: EXPERIMENTAL
Intervention: Tamoxifen 40 mg daily for 2 years
Number of subjects: 826

Group type: COMPARATOR
Intervention: No endocrine treatment
Number of subjects: 826
Study: 30634393

Group type: EXPERIMENTAL
Intervention: lactofermented Annurca apple puree (lfAAP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: unfermented apple puree (AAP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: probiotic alone (LAB)
Number of subjects: 90
Study: 27890473

Group type: EXPERIMENTAL
Intervention: Participants who ate alone for one session in the absence of social influence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants who ate alone for two or three prior sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants who ate alone for three sessions prior to exposure to high eating norm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants who ate alone following a session with norm-setting remote confederates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low eating norm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High eating norm
Number of subjects: 0
Study: 25119511

Group type: EXPERIMENTAL
Intervention: 400 mg IBUNa (Advil Film Coated Tablets)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: 400 mg IBUAdv (standard ibuprofen)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: 400 mg IBUMot (standard ibuprofen)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316
Study: 23670357

Group type: EXPERIMENTAL
Intervention: No-load condition (body weight)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Vertical jumps with stretch-shortening cycle (SSC)
Number of subjects: 13
Study: 21307868

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 31

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 31
Study: 18555744

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (6 g/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sunflower oil (control)
Number of subjects: 25